亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > Alarelin阿拉瑞林79561-22-1
Alarelin阿拉瑞林79561-22-1
單價 10.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 10000g起訂1g
品牌 成都云希
CAS號 79561-22-1
純度 ≥98%
過期 長期有效
更新 2021-07-21 15:06
 
詳細信息

Name:Alarelin Acetate阿拉瑞林

Cas No: 79561-22-1

Formula: C56H78N16O12

Molecular:1167.31

Sequence: pyroGlu-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NH-ethyl

Also known as: 79561-22-1, AGN-PC-00J5UN, 67910-55-8, [D-Ala6,Des-Gly10]-LH-RH Ethylamide,pyroGlu-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NH-ethyl

 

產品參數:

 

INCI名稱:阿拉瑞林

形狀:白色粉末

PH:無

純度:95%

儲存條件:2~8℃密封避光儲存,長期存儲建議零下15~20℃冷藏最佳

安全性:無重金屬,無皮膚及眼刺激

包裝規格:1/




©2025 成都云希化工有限公司 版權所有   技術支持:化工網   訪問量:41624  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |